Pulse 탐색 nav.journalClub 토론 트렌드 연구자 저널

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

홈 탐색 nav.journalClub 트렌드

⌘+K

Medication for Opioid Use Disorder and Perioperative Outcomes for Benign Hysterectomy. | Synapse

January 23, 20260 citationsOpen Access

View Full Paper

Medication for Opioid Use Disorder and Perioperative Outcomes for Benign Hysterectomy.

YHYongmei HuangColumbia University ALAng LiChinese Academy of Sciences JHJune Y. HouNewYork–Presbyterian Hospital

Key Points

This research investigates the impact of medication for opioid use disorder on perioperative outcomes in patients undergoing hysterectomy.
Observed patients with opioid use disorder (OUD) undergoing hysterectomy.
Evaluated the use of medication for opioid use disorder (MOUD) during the perioperative period.
Analyzed complication rates and healthcare utilization.
MOUD use, particularly methadone and buprenorphine, was linked to fewer perioperative complications.
Patients using MOUD for more than 90 days had significantly improved surgical outcomes.
Overall healthcare utilization decreased in patients receiving MOUD.

Abstract

Among patients with OUD undergoing hysterectomy, MOUD use was associated with reduced perioperative complications and health care utilization. Findings support methadone and buprenorphine use to improve hysterectomy surgical outcomes, particularly with more than 90 days of MOUD.

AI에게 질문

Like

Bookmark

Share

View Full Paper

Cite This Study

Huang et al. (Sun,) studied this question.

synapsesocial.com/papers/69731005c8125b09b0d1fcef https://doi.org/https://doi.org/10.1097/og9.0000000000000146

AI에게 질문

Like

Bookmark

Share

View Full Paper